Novel inhibitors of the high-affinity L-proline transporter as potential therapeutic agents for the treatment of cognitive disorders

Copyright © 2014 Elsevier Ltd. All rights reserved..

The incidence of cognitive disorders such as Alzheimer's disease continues to increase unabated. While cures for such diseases have eluded investigators, progress is being made on alleviating certain symptoms of these diseases. Mouse knockouts of the proline transporter (PROT), a high affinity Na(+)/Cl(-)-dependent transporter, indicated its potential as a novel therapeutic target for cognition improvement. Herein we report our investigation into a novel class of PROT inhibitors.

Medienart:

E-Artikel

Erscheinungsjahr:

2014

Erschienen:

2014

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

Bioorganic & medicinal chemistry letters - 24(2014), 16 vom: 15. Aug., Seite 3886-90

Sprache:

Englisch

Beteiligte Personen:

Zipp, G Greg [VerfasserIn]
Barbosa, Joseph [VerfasserIn]
Green, Michael A [VerfasserIn]
Terranova, Kristen M [VerfasserIn]
Fink, Cynthia [VerfasserIn]
Yu, Xuan-Chuan [VerfasserIn]
Nouraldeen, Amr [VerfasserIn]
Wilson, Alan [VerfasserIn]
Savelieva, Katerina [VerfasserIn]
Lanthorn, Thomas H [VerfasserIn]
David Kimball, S [VerfasserIn]

Links:

Volltext

Themen:

Acyl piperazine
Alzheimer’s disease
Amino Acid Transport Systems, Neutral
Dimentia
Inhibitor
Journal Article
Proline transport protein
Proline transporter
Small Molecule Libraries

Anmerkungen:

Date Completed 06.03.2015

Date Revised 11.08.2014

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.bmcl.2014.06.049

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM240193660